171 - Two Vax's and a MAB: What's New in RSV Prevention

171 - Two Vax's and a MAB: What's New in RSV ...

Up next

197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence. Key Concepts A few existing agents now have ASCV ...  Show more

196 - Stretching the Stroke Clock to 2026: A Brief Review of the 2026 Acute Ischemic Stroke Guidelines

In this episode, we review key updates from the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, including changes to IV thrombolysis, antiplatelet therapy, endovascular treatment, blood pressure goals, and glycemic goals. Key Concepts Tenec ...  Show more

Recommended Episodes

Vaccination of Adults with Cancer Guideline
ASCO Guidelines

Dr. Lisa Law and Dr. Randy Taplitz share the latest evidence-based recommendations from ASCO on vaccines in adults with cancer. They discuss recommended routine preventative vaccinations, additional vaccinations and revaccinations for adults undergoing HSCT, CD19 CAR-T treatment, ...  Show more

S2 Episode 2: When Viral Pandemics Collide: Vaccinating, Boosting and Caring for Patients Diagnosed With HIV During the Time of COVID
Medscape InDiscussion: HIV

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more

RSV and Vaccine Hesitancy
Respiratory Exchange

Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messag ...  Show more

#144 RSV & What Makes Vaccine Trials Different: Beyond Journal Club on the RENOIR and AReSVi Trials
Core IM | Internal Medicine Podcast

How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to ...  Show more